Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
CA 2504818 C · Owner: Tavares, Daniel · Inventors: Lutz, Robert J.; Hoffee, Mary G.; Tavares, Daniel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to antibodies that bind CD33. More particularly the invention relates to anti-CD33 antibodies fragments and homologues of , said antibodies humanized and resurfaced versions of said antibodies functional equivalents and improved versions of said antibodies immunoconjugates and compositions comprising said antibodies and the uses of , same in diagnostic, research and therapeutic applications. The invention also relates to a polynucleotide encoding the antibodies vectors comprising the , polynucleotides host cells transformed with polynucleotides and methods of producing the antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 5, 2003 and granted April 23, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 5, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 5, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.